UNITED STATES JUDICIAL PANEL on MULTIDISTRICT LITIGATION <TES DIST, Certified to be a true and LO” fie Co correct copy of the document on file his Angela E. Noble, Clerk, IN RE: ZANTAC (RANITIDINE) PRODUCTS [f= ag 3 Suierreen tect tare LIABILITY LITIGATION Kale s ay _ Patriok Edwards MDL No. 2924 ep ain AS, Deputy Clerk tistics Date _Mar 15, 2023 (SEE ATTACHED SCHEDULE) FILED

CONDITIONAL TRANSFER ORDER (CTO -113) wo ES □□□□□ □□□□

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to

. See

(J.P.M.L. 2020). Since that time, 416 additional action(s) have been transferred to the Southern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable Robin L. Rosenberg. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Florida and assigned to Judge Rosenberg. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under

to the Southern District of Florida for the reasons stated in the order of February 6, 2020, and, with the consent of that court, assigned to the Honorable Robin L. Rosenberg. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Southern District of Florida. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this □□□□□ period, the stay will be continued until further order of the Panel.

—_—— FOR THE PANEL: Inasmuch as no objection is covisttted time, the LL 2 Mar 13, 2023 CLERK'S OFFICE ET John W. Nichols Clerk of the Panel

IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION MDL No. 2924 SCHEDULE CTO−113 − TAG−ALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

CALIFORNIA NORTHERN CAN 3 23−00827 Andrews v. GlaxoSmithKline, LLC et al VACATED 3/13/23 CAN 3 23−00821 Porras v. GlaxoSmithKline, LLC et al